Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Clinical trial NCT06096337 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06096337
- Sponsor
- Boston Scientific Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-28
- Primary completion
- 2026-02-04
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.